Feasibility and Outcomes of an Exercise Intervention for Chemotherapy-Induced Heart Failure.


Journal

Journal of cardiopulmonary rehabilitation and prevention
ISSN: 1932-751X
Titre abrégé: J Cardiopulm Rehabil Prev
Pays: United States
ID NLM: 101291247

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 26 4 2019
pubmed: 26 4 2019
medline: 21 7 2020
Statut: ppublish

Résumé

Cancer treatment-related heart failure (HF) is an emerging health concern, as the number of survivors is increasing rapidly, and cardiac health issues are a leading cause of mortality in this population. While there is general evidence for the efficacy of exercise rehabilitation interventions, more research is needed on exercise rehabilitation interventions for patients specifically with treatment-induced HF and whether such interventions are safe and well-accepted. This study provides feasibility and health outcomes of a pilot exercise intervention for cancer survivors with chemotherapy-induced HF. Twenty-five participants were randomized to a clinic-based exercise intervention or a wait-list control group or, alternatively, allowed to enroll in a home-based exercise intervention if they declined the randomized study. For purposes of analysis, both types of exercise programs were combined into a single intervention group. Repeated-measures analysis of variance was conducted to assess for significant time and treatment group main effects separately and time × treatment group interaction effects. Significant improvements in maximum oxygen uptake ((Equation is included in full-text article.)O2max) were observed in the intervention group. Intervention satisfaction and adherence were high for both clinic- and home-based interventions, with no reported serious adverse events. Enrollment was initially low for the clinic-based intervention, necessitating the addition of the home-based program as an intervention alternative. Results suggest that exercise rehabilitation interventions are feasible in terms of safety, retention, and satisfaction and have the potential to improve (Equation is included in full-text article.)O2max. To maximize adherence and benefits while minimizing participant burden, an ideal intervention may incorporate elements of both clinic-based supervised exercise sessions and a home-based program.

Identifiants

pubmed: 31022003
doi: 10.1097/HCR.0000000000000388
pii: 01273116-201905000-00011
pmc: PMC6492623
mid: NIHMS1507389
doi:

Substances chimiques

Antineoplastic Agents 0

Banques de données

ClinicalTrials.gov
['NCT00633633']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-203

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA057730
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA056452
Pays : United States
Organisme : NCI NIH HHS
ID : R25 CA057712
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA135016
Pays : United States

Références

J Phys Act Health. 2012 Feb;9(2):225-36
pubmed: 22368222
Circ Heart Fail. 2016 Feb;9(2):e002843
pubmed: 26839395
J Am Heart Assoc. 2015 Jun 26;4(7):
pubmed: 26116691
Cochrane Database Syst Rev. 2001;(1):CD001800
pubmed: 11279730
Behav Res Methods. 2013 Sep;45(3):792-812
pubmed: 23184532
Eur J Heart Fail. 2010 Jul;12(7):706-15
pubmed: 20494922
J Clin Oncol. 2005 Oct 20;23(30):7685-96
pubmed: 16234530
J Card Fail. 2008 Aug;14(6):497-507
pubmed: 18672198
J Clin Oncol. 2007 Sep 1;25(25):3808-15
pubmed: 17664460
J Clin Oncol. 2014 Aug 10;32(23):2496-502
pubmed: 25002717
Circulation. 2007 Jun 19;115(24):3086-94
pubmed: 17548726
BMJ. 1992 Jul 18;305(6846):160-4
pubmed: 1285753
J Cardiopulm Rehabil Prev. 2015 Mar-Apr;35(2):130-9
pubmed: 25407596
J Clin Oncol. 2005 Dec 1;23(34):8597-605
pubmed: 16314622
Eur J Cancer. 2013 Sep;49(13):2900-9
pubmed: 23706982
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33
pubmed: 21051654
Nat Rev Cancer. 2007 May;7(5):332-44
pubmed: 17457301
CA Cancer J Clin. 2016 Jul;66(4):309-25
pubmed: 26919165
Circ Heart Fail. 2015 Jan;8(1):33-40
pubmed: 25399909
BMJ. 2004 Jan 24;328(7433):189
pubmed: 14729656
JAMA. 2009 Apr 8;301(14):1439-50
pubmed: 19351941
Circulation. 1999 Mar 9;99(9):1173-82
pubmed: 10069785
J Am Coll Cardiol. 2001 Dec;38(7):2101-13
pubmed: 11738322
Expert Rev Anticancer Ther. 2006 Sep;6(9):1249-69
pubmed: 17020459
Circulation. 2003 Aug 5;108(5):554-9
pubmed: 12860904
J Exerc Sci Fit. 2011;9(1):65-73
pubmed: 21709755
J Clin Oncol. 2005 Apr 20;23(12):2629-36
pubmed: 15837978
Am J Med. 2004 May 15;116(10):682-92
pubmed: 15121495

Auteurs

Edward Tsai (E)

Department of Health Promotion & Behavioral Sciences, The University of Texas School of Public Health, Houston (Mr Tsai); Department of Behavioral Science (Mr Tsai, Ms Harrison, and Dr Basen-Engquist), Department of Cardiology, Division of Internal Medicine (Drs Mouhayar and Durand), Department of Biostatistics (Dr Song), Department of Nursing (Dr Fadol), and Clinical Research Support Center (Ms Massey), The University of Texas MD Anderson Cancer Center, Houston; and Cardiovascular Division, Washington University School of Medicine in St Louis, St Louis, Missouri (Dr Lenihan).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH